Trial intelligence / Profile preview

Intubation Conditions in Morbidly Obese Patients with Rapid Sequence Induction

2025-520977-37-00Phase 4Withdrawn

Sponsor
UZ Brussel
Start
Nov 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of rocuronium in obesity (2 arms), sponsored by UZ Brussel. Planned start Nov 2025; status: withdrawn.

02

Drugs

rocuronium
03

Conditions

obesity

Beyond the preview

Go deeper on 2025-520977-37-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2025-520977-37-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call